IN2015DN01547A - - Google Patents
Download PDFInfo
- Publication number
- IN2015DN01547A IN2015DN01547A IN1547DEN2015A IN2015DN01547A IN 2015DN01547 A IN2015DN01547 A IN 2015DN01547A IN 1547DEN2015 A IN1547DEN2015 A IN 1547DEN2015A IN 2015DN01547 A IN2015DN01547 A IN 2015DN01547A
- Authority
- IN
- India
- Prior art keywords
- compounds
- methods
- compositions
- variables
- articles
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 abstract 1
- 206010061218 Inflammation Diseases 0.000 abstract 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 abstract 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 abstract 1
- 239000003963 antioxidant agent Substances 0.000 abstract 1
- 230000003078 antioxidant effect Effects 0.000 abstract 1
- 230000004054 inflammatory process Effects 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 229940100243 oleanolic acid Drugs 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/10—1,3,4-Oxadiazoles; Hydrogenated 1,3,4-oxadiazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J63/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by expansion of only one ring by one or two atoms
- C07J63/008—Expansion of ring D by one atom, e.g. D homo steroids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D271/00—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms
- C07D271/02—Heterocyclic compounds containing five-membered rings having two nitrogen atoms and one oxygen atom as the only ring hetero atoms not condensed with other rings
- C07D271/06—1,2,4-Oxadiazoles; Hydrogenated 1,2,4-oxadiazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Epidemiology (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Lubricants (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201261699199P | 2012-09-10 | 2012-09-10 | |
| PCT/US2013/059015 WO2014040056A1 (fr) | 2012-09-10 | 2013-09-10 | Dérivés c17-hétéroarylés de l'acide oléanolique et leurs procédés d'utilisation |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IN2015DN01547A true IN2015DN01547A (fr) | 2015-07-03 |
Family
ID=49253401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IN1547DEN2015 IN2015DN01547A (fr) | 2012-09-10 | 2013-09-10 |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US20140088163A1 (fr) |
| EP (1) | EP2892911B1 (fr) |
| JP (1) | JP6272870B2 (fr) |
| KR (1) | KR102237364B1 (fr) |
| CN (1) | CN104768965B (fr) |
| AU (1) | AU2013312102B2 (fr) |
| BR (1) | BR112015005200B1 (fr) |
| CA (1) | CA2882417C (fr) |
| CY (1) | CY1119762T1 (fr) |
| DK (1) | DK2892911T3 (fr) |
| EA (1) | EA029069B1 (fr) |
| ES (1) | ES2644615T3 (fr) |
| HK (1) | HK1211295A1 (fr) |
| HR (1) | HRP20171565T1 (fr) |
| HU (1) | HUE036797T2 (fr) |
| IL (1) | IL237638B (fr) |
| IN (1) | IN2015DN01547A (fr) |
| LT (1) | LT2892911T (fr) |
| ME (1) | ME02911B (fr) |
| MX (1) | MX366954B (fr) |
| NZ (1) | NZ705213A (fr) |
| PL (1) | PL2892911T3 (fr) |
| PT (1) | PT2892911T (fr) |
| RS (1) | RS56563B1 (fr) |
| SG (1) | SG11201501800UA (fr) |
| SI (1) | SI2892911T1 (fr) |
| WO (1) | WO2014040056A1 (fr) |
| ZA (1) | ZA201501203B (fr) |
Families Citing this family (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2009089545A1 (fr) | 2008-01-11 | 2009-07-16 | Reata Pharmaceuticals, Inc. | Triterpénoïdes synthétiques et procédés d'utilisation dans le traitement de maladies |
| CA2721838C (fr) | 2008-04-18 | 2017-05-23 | Reata Pharmaceuticals, Inc. | Modulateurs d'inflammation antioxydants: derives d'acide oleanolique presentant une modification du groupe amino et d'autres modifications en c-17 |
| MX2010011435A (es) | 2008-04-18 | 2011-01-25 | Reata Pharmaceuticals Inc | Compuestos que incluyen un nucleo farmaceutico antiinflamatorio y sus metodos de uso. |
| US8513436B2 (en) | 2010-12-17 | 2013-08-20 | Reata Pharmaceuticals, Inc. | Pyrazolyl and pyrimidinyl tricyclic enones as antioxidant inflammation modulators |
| WO2013163344A1 (fr) | 2012-04-27 | 2013-10-31 | Reata Pharmaceuticals, Inc. | Dérivés 2,2-difluoropropionamide de bardoxolone méthyle, leurs formes polymorphes et leurs procédés d'utilisation |
| US9556222B2 (en) | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
| US9512094B2 (en) | 2012-09-10 | 2016-12-06 | Reata Pharmaceuticals, Inc. | C17-heteroaryl derivatives of oleanolic acid and methods of use thereof |
| DK2892912T3 (da) | 2012-09-10 | 2019-06-24 | Reata Pharmaceuticals Inc | C17-alkandiyl og alkenediylderivater af oleanolsyre og fremgangsmåder til anvendelse deraf |
| TWI649330B (zh) | 2013-04-24 | 2019-02-01 | 艾伯維有限公司 | 甲基巴多索龍之２，２－二氟丙醯胺衍生物、其多晶形及其使用方法 |
| KR20240035818A (ko) | 2015-02-12 | 2024-03-18 | 리아타 파마슈티컬즈, 아이엔씨. | 항산화 염증 조절제로서의 이미다졸릴 트리사이클릭 에논 |
| KR20180061251A (ko) | 2015-09-23 | 2018-06-07 | 리아타 파마슈티컬즈, 아이엔씨. | Il-17의 저해를 위한 c4-변형된 올레아놀산 유도체 및 다른 용도 |
| KR102486434B1 (ko) | 2016-11-08 | 2023-01-09 | 리아타 파마슈티컬즈 홀딩스, 엘엘씨 | 바독솔론 메틸 또는 이의 유사체를 사용하는 알포트 증후군의 치료 방법 |
| CN106632574B (zh) * | 2016-12-07 | 2018-05-29 | 广东天键生物科技有限公司 | 一种化合物、其制备方法及用途 |
| TWI831738B (zh) | 2016-12-16 | 2024-02-11 | 美商瑞塔醫藥有限責任公司 | 用於抑制ＲＯＲγ及其他用途的嘧啶三環烯酮衍生物 |
| JP6820450B2 (ja) | 2017-09-14 | 2021-01-27 | フェニックス・バイオテクノロジー・インコーポレイテッド | ウイルス感染を治療するための方法および組成物 |
| KR20200083969A (ko) | 2017-09-14 | 2020-07-09 | 피닉스 바이오테크놀러지 인코포레이티드. | 신경학적 상태를 치료하기 위한 방법 및 개선된 신경보호 조성물 |
| US11993574B2 (en) | 2018-06-15 | 2024-05-28 | Reata Pharmaceuticals, Inc | Pyrazole and imidazole compounds for inhibition of IL-17 and RORgamma |
| CA3114354A1 (fr) * | 2018-09-28 | 2020-04-02 | Sichuan Haisco Pharmaceutical Co., Ltd. | Derives de terpinoides et leurs utilisations |
| KR20220044942A (ko) * | 2019-07-19 | 2022-04-12 | 리아타 파마슈티컬즈, 아이엔씨. | C17 극성-치환된 헤테로방향족 합성 트리터페노이드 및 그의 사용 방법 |
| SG11202105728YA (en) | 2020-03-31 | 2021-11-29 | Phoenix Biotechnology Inc | Method and compositions for treating coronavirus infection |
| EP4009981B1 (fr) | 2020-03-31 | 2023-08-16 | Phoenix Biotechnology, Inc. | Méthode et compositions pour le traitement d'une infection à coronavirus |
| JP7214696B2 (ja) * | 2020-10-01 | 2023-01-30 | 一般財団法人 化学物質評価研究機構 | 新規ｉｎ ｖｉｔｒｏ皮膚感作性試験法 |
| EP4259155A1 (fr) | 2020-12-11 | 2023-10-18 | Reata Pharmaceuticals Holdings, LLC | Triterpénoïdes synthétiques destinés à être utilisés en thérapie |
| EP4277916A1 (fr) | 2021-01-18 | 2023-11-22 | Reata Pharmaceuticals, Inc. | Dérivés d'acide ursolique synthétique et leurs procédés d'utilisation |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6326507B1 (en) * | 1998-06-19 | 2001-12-04 | Trustees Of Dartmouth College | Therapeutic compounds and methods of use |
| CA2485565A1 (fr) * | 2002-05-13 | 2004-08-05 | Trustees Of Dartmouth College | Inhibiteurs et procedes d'utilisation de ceux-ci |
| WO2009089545A1 (fr) | 2008-01-11 | 2009-07-16 | Reata Pharmaceuticals, Inc. | Triterpénoïdes synthétiques et procédés d'utilisation dans le traitement de maladies |
| BRPI0911422B8 (pt) | 2008-04-18 | 2021-05-25 | Reata Pharmaceuticals Inc | compostos moduladores inflamatórios antioxidantes, composição farmacêutica e usos dos mesmos |
| CA2721838C (fr) | 2008-04-18 | 2017-05-23 | Reata Pharmaceuticals, Inc. | Modulateurs d'inflammation antioxydants: derives d'acide oleanolique presentant une modification du groupe amino et d'autres modifications en c-17 |
| CN102164941B (zh) * | 2008-04-18 | 2015-05-27 | 里亚塔医药公司 | 抗氧化剂炎症调节剂:具有饱和c环的齐墩果酸衍生物 |
| WO2009146216A2 (fr) | 2008-04-18 | 2009-12-03 | Reata Pharmaceuticals. Inc. | Modulateurs d’inflammation antioxydant : nouveaux dérivés d’acide oléanolique |
| MX348862B (es) * | 2011-03-11 | 2017-07-03 | Reata Pharmaceuticals Inc | Derivados c4-monometil triterpenoides y sus metodos de uso. |
| US9556222B2 (en) * | 2012-06-15 | 2017-01-31 | Reata Pharmaceuticals, Inc. | A-ring epoxidized triterpenoid-based anti-inflammation modulators and methods of use thereof |
-
2013
- 2013-09-10 SI SI201330818T patent/SI2892911T1/sl unknown
- 2013-09-10 SG SG11201501800UA patent/SG11201501800UA/en unknown
- 2013-09-10 BR BR112015005200-2A patent/BR112015005200B1/pt active IP Right Grant
- 2013-09-10 PL PL13767175T patent/PL2892911T3/pl unknown
- 2013-09-10 JP JP2015531317A patent/JP6272870B2/ja active Active
- 2013-09-10 AU AU2013312102A patent/AU2013312102B2/en active Active
- 2013-09-10 DK DK13767175.6T patent/DK2892911T3/en active
- 2013-09-10 EA EA201590539A patent/EA029069B1/ru unknown
- 2013-09-10 CA CA2882417A patent/CA2882417C/fr active Active
- 2013-09-10 PT PT137671756T patent/PT2892911T/pt unknown
- 2013-09-10 MX MX2015003078A patent/MX366954B/es active IP Right Grant
- 2013-09-10 IN IN1547DEN2015 patent/IN2015DN01547A/en unknown
- 2013-09-10 KR KR1020157009160A patent/KR102237364B1/ko active IP Right Grant
- 2013-09-10 NZ NZ705213A patent/NZ705213A/en unknown
- 2013-09-10 US US14/022,843 patent/US20140088163A1/en not_active Abandoned
- 2013-09-10 CN CN201380057684.2A patent/CN104768965B/zh active Active
- 2013-09-10 WO PCT/US2013/059015 patent/WO2014040056A1/fr active Application Filing
- 2013-09-10 ME MEP-2017-254A patent/ME02911B/fr unknown
- 2013-09-10 RS RS20171140A patent/RS56563B1/sr unknown
- 2013-09-10 HU HUE13767175A patent/HUE036797T2/hu unknown
- 2013-09-10 EP EP13767175.6A patent/EP2892911B1/fr active Active
- 2013-09-10 ES ES13767175.6T patent/ES2644615T3/es active Active
- 2013-09-10 LT LTEP13767175.6T patent/LT2892911T/lt unknown
-
2015
- 2015-02-23 ZA ZA2015/01203A patent/ZA201501203B/en unknown
- 2015-03-09 IL IL237638A patent/IL237638B/en active IP Right Grant
- 2015-12-07 HK HK15112022.0A patent/HK1211295A1/xx unknown
-
2017
- 2017-10-16 HR HRP20171565TT patent/HRP20171565T1/hr unknown
- 2017-11-03 CY CY20171101157T patent/CY1119762T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IN2015DN01547A (fr) | ||
| IN2015DN01442A (fr) | ||
| MX348862B (es) | Derivados c4-monometil triterpenoides y sus metodos de uso. | |
| WO2012083306A3 (fr) | Pyrazolyl- et pyrimidinyl-énones tricycliques en tant que modulateurs d'inflammation antioxydants | |
| WO2009129545A8 (fr) | Modulateurs d'inflammation antioxydants: dérivés d'acide oléanolique présentant une saturation dans l'anneau c | |
| PH12016501192A1 (en) | Tetrahydropyridopyrazines modulators of gpr6 | |
| MX2011008864A (es) | Tetrahidroazolopirazinas sulfoniladas y su uso como productos medicinales. | |
| UA110354C2 (uk) | Противірусні сполуки | |
| MX2015013042A (es) | Compuestos organicos. | |
| PT2470546E (pt) | Compostos de hexa-hidrooxazinopteridina para serem utilizados como inibidores de mtor | |
| MX350211B (es) | Proceso para la preparacion del etil-ester del acido n- (4-ciclohexil-3-trifluoro-metil-benciloxi) -acetimidico. | |
| MY166449A (en) | Pharmaceutical composition of rosuvastatin calcium | |
| GEP20207108B (en) | Substituted 2,4 diamino-quinoline as new anticancer agents | |
| IN2014MN01469A (fr) | ||
| IN2015DN00950A (fr) | ||
| IN2014MN02393A (fr) | ||
| NZ705902A (en) | Isoxazolidine derivatives | |
| AU2013347232A8 (en) | 3-Aminocyclopentane carboxamide derivatives | |
| MX348841B (es) | Derivados de pirimidooxazocina como inhibidores de mtor. | |
| MX2013006670A (es) | Derivado de 2-carboxamida-4-piperazinil-benzofurano. | |
| CR20120109A (es) | Nuevos derivados dihidro-oxazolobenzodiazepinonas, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| GEP20156247B (en) | Novel dihydrobenzoxathiazepine derivatives, preparation thereof, and pharmaceutical compositions containing them | |
| IN2013MU02279A (fr) |